# Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/belimumab-in-the-treatment-of-systemic-lupus-erythematosus-high-disease-activity/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ronald van Vollenhoven,Michelle Petri,Ricard Cervera,David A. Roth,Beulah Ji,C. Kleoudis,Z. John Zhong,William W. Freimuth |
| Citations | 414 |
| DOI | 10.1136/annrheumdis-2011-200937 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ard.bmj.com/content/annrheumdis/71/8/1343.full.pdf |
| OpenAlex ID | https://openalex.org/W2119296184 |
| PMID | 22337213 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Ronald van Vollenhoven](https://scholariq.org/researchers/ronald-van-vollenhoven/)
- [Michelle Petri](https://scholariq.org/researchers/michelle-petri/)
- [David A. Roth](https://scholariq.org/researchers/david-a-roth/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.